Sun Siyu, Tuo Qinhui, Li Dongxu, Wang Xiulong, Li Xuefang, Zhang Yiyue, Zhao Guoan, Lin Fei
The Cardiovascular Research Center, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453003, China.
The School of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
Evid Based Complement Alternat Med. 2020 Sep 26;2020:9568647. doi: 10.1155/2020/9568647. eCollection 2020.
Cardiovascular disease is one of the main human health risks, and the incidence is increasing. Salidroside is an important bioactive component of L., which is used to treat Alzheimer's disease, tumor, depression, and other diseases. Recent studies have shown that salidroside has therapeutic effects, to some degree, in cardiovascular diseases via an antioxidative mechanism. However, evidence-based clinical data supporting the effectiveness of salidroside in the treatment of cardiovascular diseases are limited. In this review, we discuss the effects of salidroside on cardiovascular risk factors and cardiovascular diseases and highlight potential antioxidant therapeutic strategies.
心血管疾病是人类主要的健康风险之一,且发病率正在上升。红景天苷是红景天属植物的一种重要生物活性成分,可用于治疗阿尔茨海默病、肿瘤、抑郁症等疾病。最近的研究表明,红景天苷通过抗氧化机制在一定程度上对心血管疾病具有治疗作用。然而,支持红景天苷治疗心血管疾病有效性的循证临床数据有限。在本综述中,我们讨论了红景天苷对心血管危险因素和心血管疾病的影响,并强调了潜在的抗氧化治疗策略。